Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Solitary thyroid nodule Hystory Low dose radiation Family hystory Physical exam Diagnostic test FNA 65% BENIGN 20%SUSPICIOUS 5%MALIGNANT 15%NONDIAGNOSTIC 1%FULSE POSITIVE 3%FULSE NEGATIVE LABORATORY STUDIES EUTHYROID TSH TG CALCITONIN CEA IMAGING SONOGRAPHY CT SCAN MRI THYROID SCAN MANABNGEMENT MALIGNANT THYROIDECTOMY CYST PAPILARY THYROID CANCER 80% OF THYROID CA in iodine sufficient area and children and radiation exposed patients female:male ratio 2/1 Age30-40 Euthyroid Lymphatic metastasis Metastasis to long bone liver brain pathology Section Psommama bodies Multifocl 85% Prognostic indicator 95% 10years sur Prognostic factors Age Hystologic grade Tumor size Differentiation External thyroid invation& metastasis Surgical treatment high risk patient = total or near total thyroidectomy Minimaly ptc = lobectomy isthmectomy If no angioinvation no mutifocal no positive margin In low risk patient type of surgery is cotraversy Type of surgery in low risk Total or near total Lobectomy isthmectomy Follicular carcinoma 10% of thyroid cancer Often in iodine deficiency area F:m ratio = 3/1 50 years Pain is rare Lymphadenopathy is rare5% 1% hot nodule FNA In follicular is not diagnostic pathology Vascular and capsular invation Minimally invasive tumor Surgical treatment &prognosis Minimally invasive=lobectomy frankely invasive ca =total thyroidectomy Patient with angioinvation=total thyroidectomy Node disectoin if lymph node is + not prophylaxy Hurthle cell ca 3%of thyroid ca Sub type of follicular Fna same as follicular Multifocal and multy center 30%rai uptake no or low Local lymph node 30% treatment same as ftc hurthle cell adenma=lobectomy hurthle cellca total thyroidectomy Same asmtc routine central node disection Lateral node+=MND RAI scan and ablation not effective Post opperative manangment of differentiated thyroid ca Thyroid hormone TG SONO CT MRI of neck must be done in high risk patient Radioiodine therapy External beam radiotherapy& chemotherapy Medullary thyroid cancer 5% of thyroid ca C-cell MTC is often sporadically 25% is familial 15-20% lymphadenopathy at the time of diagnosis Pain is common Dysphagea and dysnea and dysphonea may be Metastas to liver bone(osteoblastic) lung M f:m ratio1/1/2 50—6o Calcitonin cea serotonin pr e2 f2alfa MTC DIARHEA Cushing.s syn ectopic ACTH PATHOLOGY IN SPORADIC 80%UNILATERAL INFAMILIAL TYPE 90%BILATERAL AND MULTICENTERAL AMYLOID IS DIAGNOSTIC DIAGNOSIS HYSTORY PHYSICAL EXAME SERUM CALCITONIN AND CEA FNA TREATMENT Gold standard therapy is total thyroidectomy if may be becouse Bilateral central neck node disection MND in node positive and tumor greater than 1/5 cm External radiotherapy is debate residual tumor unresectable recurence RF or radiofrequency Anaplastic ca 1% Women 70-80 Rapidly enlarge neck mass Dysnea dysphonea dysphagea are common Fixed may be ulcerated often lymph node possitive Diagnosis and treatment FNA occasionally incisional biopsy Poor prognosis limphoma Non-hdgkin b-cell type Most commonly from chronic lymphocytic thyroiditis Symptom same anaplastic ca diagnosis Often with FNA Needle core biopsy or open biopsy may be needed treatment Chemothrapy Radiotherapy thyroidectomy Metastatic ca Is rare Kidney Breast Lung melanoma Complication of thyroid surgery RLN INJERY EXTERNAL BERANCH OF SUP LARING N INJERY NECK SYMPATHETIC NERVE INJURY HYPOCALCEMIA AND HYPOPARATHYROIDISM HEMATOMA HEMORHAGE SEROMA CELULITIS INFECTION JUGULAR VEIN AND CAROTID AND ESOPHGUSE INJERY IS RARE ..